Cisco
CSCO
Alibaba
BABA
Disney
DIS
4
Apple
AAPL
5
Qualcomm
QCOM
US Stock MarketDetailed Quotes
SNY Sanofi
- 54.500
- -0.950-1.71%
Close Mar 26 16:00 ET
- 54.500
- 0.0000.00%
Post 16:28 ET
133.42BMarket Cap22.88P/E (TTM)
54.840High53.980Low3.00MVolume54.370Open55.450Pre Close163.73MTurnover0.14%Turnover Ratio22.88P/E (Static)2.45BShares60.11552wk High1.60P/B120.22BFloat Cap43.38152wk Low1.95Dividend TTM2.21BShs Float60.115Historical High3.57%Div YieldTTM1.55%Amplitude8.844Historical Low54.530Avg Price1Lot Size
About Sanofi Company
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Company Profile
SymbolSNY
Company NameSanofi
Founded1994
CEOMr. Paul Hudson
MarketNASDAQ
Employees82878
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends12-31
Address46, avenue de la Grande Armée
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75017
Phone33-1-53-77-40-00
Websitehttp://www.sanofi.com
Company Executives
- Name
- Position
- Salary
- Paul Hudson
- Director and Chief Executive Officer
- --
- Natalie Bickford
- Executive Vice President and Chief People Officer
- --
- Francois-Xavier Roger
- Executive Vice President and Chief Financial Officer
- --
- Emmanuel Frenehard
- Executive Vice President and Chief Digital Officer
- --
- Julie Van Ongevalle
- Executive Vice President, Consumer Healthcare
- --
- Houman Ashrafian
- Executive Vice President and Head of Research and Development
- --
- Brian Foard
- Executive Vice President, Specialty Care
- --
- Audrey Duval
- Executive Vice President, Corporate Affairs
- --
- Olivier Charmeil
- Executive Vice President, General Medicines
- --
- Thomas Triomphe
- Executive Vice President, Vaccines
- --
- Roy Papatheodorou
- Executive Vice President and General Counsel
- --
- Brendan O'Callaghan
- Executive Vice President, Global Manufacturing & Supply
- --
- Madeleine Roach
- Executive Vice President, Business Operations
- --
- Frederic Oudea
- Chairman of the Board
- --
- Yann Tran
- Director
- 112.50K
- Wolfgang Laux
- Director
- 129.00K
- Christophe Babule
- Director
- 162.00K
- Barbara Lavernos
- Director
- 156.50K
- Lise Kingo
- Independent Director
- 167.50K
- Clotilde Delbos
- Independent Director
- 124.50K
- John Sundy
- Independent Director
- 113.50K
- Dr. Antoine Yver, M.D.,M.Sc.
- Independent Director
- 184.00K
- Patrick Kron
- Independent Director
- 195.00K
- Fabienne Lecorvaisier
- Independent Director
- 170.25K
- Anne-Francoise Nesmes
- Independent Director
- 124.50K
- Emile Voest
- Independent Director
- 159.25K
- Rachel Duan
- Independent Director
- 145.50K
- Carole Ferrand
- Independent Director
- 197.75K
- Jean-Paul Kress
- Independent Director
- --
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings